Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySat, 08 Jun 2024 15:49:23 +0200Mon, 29 Apr 2024 17:32:00 +0200Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 20/12/2021, Revision: 12, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/nuvaxovidHuman medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 20/12/2021, Revision: 12, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/nuvaxovidMon, 29 Apr 2024 17:32:00 +0200Human medicineNuvaxovid : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-1618-en.pdfNuvaxovid : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-1618-en.pdfWed, 08 Nov 2023 11:12:00 +0100Human medicine